- Home
- DPRO vs PSTV Comparison
DPRO vs PSTV Comparison
Compare DPRO & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- PSTV
- Stock Information
- Founded
- DPRO 1998
- PSTV 1996
- Country
- DPRO Canada
- PSTV United States
- Employees
- DPRO N/A
- PSTV N/A
- Industry
- DPRO Aerospace
- PSTV Medical/Dental Instruments
- Sector
- DPRO Industrials
- PSTV Health Care
- Exchange
- DPRO Nasdaq
- PSTV Nasdaq
- Market Cap
- DPRO 9.3M
- PSTV 7.9M
- IPO Year
- DPRO N/A
- PSTV N/A
- Fundamental
- Price
- DPRO $2.23
- PSTV $1.22
- Analyst Decision
- DPRO Strong Buy
- PSTV Strong Buy
- Analyst Count
- DPRO 2
- PSTV 2
- Target Price
- DPRO $7.00
- PSTV $14.00
- AVG Volume (30 Days)
- DPRO 58.9K
- PSTV 101.8K
- Earning Date
- DPRO 11-14-2024
- PSTV 11-14-2024
- Dividend Yield
- DPRO N/A
- PSTV N/A
- EPS Growth
- DPRO N/A
- PSTV N/A
- EPS
- DPRO N/A
- PSTV N/A
- Revenue
- DPRO $4,469,286.00
- PSTV $5,509,000.00
- Revenue This Year
- DPRO $30.90
- PSTV $11.13
- Revenue Next Year
- DPRO $112.38
- PSTV N/A
- P/E Ratio
- DPRO N/A
- PSTV N/A
- Revenue Growth
- DPRO N/A
- PSTV 113.20
- 52 Week Low
- DPRO $1.55
- PSTV $1.15
- 52 Week High
- DPRO $15.00
- PSTV $2.78
- Technical
- Relative Strength Index (RSI)
- DPRO 41.73
- PSTV 40.41
- Support Level
- DPRO $2.25
- PSTV $1.17
- Resistance Level
- DPRO $2.91
- PSTV $1.42
- Average True Range (ATR)
- DPRO 0.27
- PSTV 0.11
- MACD
- DPRO 0.01
- PSTV -0.01
- Stochastic Oscillator
- DPRO 25.59
- PSTV 15.63
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).